Scientific paper - Original scientific paper
BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats
Frontiers in Pharmacology, 12 (2021); 632295. https://doi.org/10.3389/fphar.2021.632295


Cite this document

Zlatar, M., Kokot, A., Batelja Vuletić, L., Masnec, S., Kralj, T., Milković Periša, M. ... Sikirić, P. (2021). BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats. Frontiers in Pharmacology, 12.. doi: 10.3389/fphar.2021.632295

Zlatar, Mirna, et al. "BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats." Frontiers in Pharmacology, vol. 12, 2021. https://doi.org/10.3389/fphar.2021.632295

Zlatar, Mirna, Antonio Kokot, Lovorka Batelja Vuletić, Sanja Masnec, Tamara Kralj, Marija Milković Periša, Ivan Barišić, et al. "BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats." Frontiers in Pharmacology 12 (2021). https://doi.org/10.3389/fphar.2021.632295

Zlatar, M., et al. (2021) 'BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats', Frontiers in Pharmacology, 12. doi: 10.3389/fphar.2021.632295

Zlatar M, Kokot A, Batelja Vuletić L, Masnec S, Kralj T, Milković Periša M, and sur.. BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats. Frontiers in Pharmacology [Internet]. 2021 June 10 [cited 2023 January 28];12. doi: 10.3389/fphar.2021.632295

M. Zlatar, et al., "BPC 157 as a Therapy for Retinal Ischemia Induced by Retrobulbar Application of L-NAME in Rats", Frontiers in Pharmacology, vol. 12, June 2021. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:095629. [Accessed: 28 January 2023]

Please login to the repository to save this object to your list.